{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:14:43Z","timestamp":1789719283355,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.trsl.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T01:02:26Z","timestamp":1487120546000},"page":"21-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-8496","authenticated-orcid":false,"given":"Andrea","family":"Piccin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Feistritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elva","family":"Eakins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Van Schilfgaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Corvetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Di Pierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pusceddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gambato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Langes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Veneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Perbellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Pacquola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Gherlinzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Mazzoleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Krampera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Gastl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2017.02.001_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2017.02.001_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2012-01-404889","article-title":"Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation","volume":"121","author":"Rosti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation.V2012.1.571.3798557","article-title":"Thrombotic disease in the myeloproliferative neoplasms","volume":"2012","author":"Falanga","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.trsl.2017.02.001_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1538-7836.2009.03531.x","article-title":"Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia","volume":"7","author":"Passamonti","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2017.02.001_bib7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2012-04-424911","article-title":"Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort","volume":"120","author":"Campbell","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","article-title":"Bleeding and thrombosis in the myeloproliferative disorders","volume":"64","author":"Schafer","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib9","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","article-title":"Leukocytosis and risk stratification assessment in essential thrombocythemia","volume":"26","author":"Carobbio","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2017.02.001_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11739-015-1186-8","article-title":"Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia","volume":"10","author":"Piccin","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.trsl.2017.02.001_bib11","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3324\/haematol.13774","article-title":"Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia","volume":"94","author":"Trappenburg","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2017.02.001_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.thromres.2010.06.025","article-title":"Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms","volume":"126","author":"Duchemin","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2017.02.001_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajh.23590","article-title":"Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia","volume":"89","author":"Marchetti","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2017.02.001_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MBC.0000000000000293","article-title":"Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience","volume":"26","author":"Kissova","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.trsl.2017.02.001_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2017.02.001_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.trsl.2017.02.001_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"European LeukemiaNet. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2017.02.001_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/leu.2011.306","article-title":"How to manage essential thrombocythemia","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.trsl.2017.02.001_bib20","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2017.02.001_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1373\/clinchem.2005.065581","article-title":"Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma","volume":"52","author":"Papassotiriou","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2017.02.001_bib22","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1161\/01.CIR.96.10.3534","article-title":"Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant","volume":"96","author":"Nieuwland","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2017.02.001_bib23","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1046\/j.1538-7836.2003.00456.x","article-title":"Human cell-derived microparticles promote thrombus formation in\u00a0vivo in a tissue factor-dependent manner","volume":"1","author":"Bir\u00f3","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib24","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1160\/TH10-12-0810","article-title":"Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease","volume":"106","author":"Mobarrez","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib26","doi-asserted-by":"crossref","first-page":"28414","DOI":"10.3402\/jev.v4.28414","article-title":"Circulating microparticles, protein C, free protein S, and endothelial vascular markers in children with sickle cell anaemia","volume":"23","author":"Piccin","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.trsl.2017.02.001_bib27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet-and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa","volume":"10","author":"Van Der Meijden","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib28","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1538-7836.2004.00936.x","article-title":"Measuring circulating cell-derived microparticles","volume":"2","author":"Jy","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib29","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1538-7836.2005.01403.x","article-title":"Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes","volume":"3","author":"Sommeijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000360600","article-title":"Endothelial microparticles and endothelial damage: \u201cThe tip and the iceberg\u201d","volume":"132","author":"Piccin","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.trsl.2017.02.001_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2006.09.001","article-title":"Circulating microparticles: pathophysiology and clinical implications","volume":"21","author":"Piccin","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.trsl.2017.02.001_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2648.2009.05250.x","article-title":"Generalizability and transferability of meta-synthesis research findings","volume":"66","author":"Finfgeld-Connett","year":"2010","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.trsl.2017.02.001_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/bmj.1.5855.700","article-title":"Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase","volume":"1","author":"Schwarzenberg","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.trsl.2017.02.001_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.1997.3503164.x","article-title":"The effects of anagrelide on human megakaryocytopoiesis","volume":"99","author":"Solberg","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2017.02.001_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2005-11-4454","article-title":"Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells","volume":"108","author":"Cokic","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.02.001_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-09-0663","article-title":"Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms","volume":"104","author":"Cella","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1476-5381.1988.tb11711.x","article-title":"Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator","volume":"95","author":"Amezcua","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2017.02.001_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)21006-0","article-title":"Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle","volume":"246","author":"Ignarro","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2017.02.001_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/lt.500050606","article-title":"Adrenomedullin in liver transplantation and its relationship with vascular complications","volume":"5","author":"F\u00e1brega","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.trsl.2017.02.001_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2017.02.001_bib41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(89)91349-1","article-title":"Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover","volume":"161","author":"Kasuya","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2017.02.001_bib42","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI116889","article-title":"E-selectin supports neutrophil rolling in\u00a0vitro under conditions of flow","volume":"92","author":"Abbassi","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2017.02.001_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/VHRM.S29144","article-title":"Endoglin: a critical mediator of cardiovascular health","volume":"9","author":"Kapur","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.trsl.2017.02.001_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/205873920601900104","article-title":"Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in\u00a0vitro and during shear stress-induced angiogenesis in\u00a0vivo","volume":"19","author":"Bongrazio","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.trsl.2017.02.001_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1160\/TH10-09-0595","article-title":"Pre-analytical and analytical issues in the analysis of blood microparticles","volume":"105","author":"Yuana","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1055\/s-0030-1267034","article-title":"Overcoming limitations of microparticle measurement by flow cytometry","volume":"36","author":"Lacroix","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.trsl.2017.02.001_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cyto.a.22685","article-title":"Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter?","volume":"89","author":"Poncelet","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.trsl.2017.02.001_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09537100802054107","article-title":"Flow cytometric measurement of microparticles: pitfalls and protocol modifications","volume":"19","author":"Shah","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.trsl.2017.02.001_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cyto.a.22892","article-title":"Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants","volume":"89","author":"Wisgrill","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.trsl.2017.02.001_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0049-3848(98)00044-9","article-title":"Interference of chylomicrons in analysis of platelets by flow cytometry","volume":"91","author":"Cantero","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2017.02.001_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.thromres.2010.12.014","article-title":"Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay","volume":"127","author":"Ayers","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2017.02.001_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/09537100903096692","article-title":"Tetraspanin CD9 is required for microparticle release from coated-platelets","volume":"20","author":"Dale","year":"2009","journal-title":"Platelets"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524417300816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524417300816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T10:46:11Z","timestamp":1749984371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524417300816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":52,"alternative-id":["S1931524417300816"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2017.02.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}